Zobrazeno 1 - 10
of 159
pro vyhledávání: '"Enrique, Trilla"'
Autor:
Juan Morote, Nahuel Paesano, Natàlia Picola, Jesús Muñoz-Rodriguez, Xavier Ruiz-Plazas, Marta V. Muñoz-Rivero, Ana Celma, Gemma García-de Manuel, Berta Miró, José M. Abascal, Pol Servian, Olga Méndez, Enrique Trilla
Publikováno v:
Life, Vol 14, Iss 11, p 1359 (2024)
The role of digital rectal examination (DRE) in the early detection of significant prostate cancer (PCa) is being questioned in the era of magnetic resonance imaging (MRI). However, some men with suspected PCa may still be identified solely through D
Externí odkaz:
https://doaj.org/article/2845262cd8b44889bde09c0118cd8248
Autor:
Juan Morote, Ángel Borque-Fernando, Marina Triquell, Miriam Campistol, Pol Servian, José M. Abascal, Jacques Planas, Olga Méndez, Luis M. Esteban, Enrique Trilla
Publikováno v:
European Urology Open Science, Vol 53, Iss , Pp 46-54 (2023)
Background: Magnetic resonance imaging (MRI)-based risk calculators (MRI-RCs) individualise the likelihood of clinically significant prostate cancer (csPCa) and improve candidate selection for prostate biopsy beyond the Prostate Imaging Reporting and
Externí odkaz:
https://doaj.org/article/4634266d2b1c4393a0c1805609d35a1c
Publikováno v:
BJUI Compass, Vol 4, Iss 3, Pp 266-268 (2023)
Externí odkaz:
https://doaj.org/article/b575bf51343e40889fdbf38150e34927
Autor:
Juan Morote, Miriam Campistol, Anna Celma, Lucas Regis, Inés de Torres, María E. Semidey, Sarai Roche, Richard Mast, Anna Santamaría, Jacques Planas, Enrique Trilla
Publikováno v:
The World Journal of Men's Health, Vol 40, Iss 2, Pp 270-279 (2022)
Purpose: To analyze how Proclarix is valuable to appropriately select candidates for multiparametric magnetic resonance imaging (mpMRI) and derived biopsies, among men with suspected prostate cancer (PCa). Proclarix is a new marker computing the cl
Externí odkaz:
https://doaj.org/article/fec9477a73fb4aefa7043d409142a337
Autor:
Mercè Cuadras, Jacques Planas, Ana Celma, Lucas Regis, Inés M. de Torres, M. Eugenia Semidey, Enrique Trilla, Juan Morote
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background Lymph node (LN) status is a key prognostic factor in the decision-making process of different cancer entities, including prostate cancer (PCa). Sectioning and haematoxylin and eosin (H&E) staining technique remain the gold standar
Externí odkaz:
https://doaj.org/article/6efc29b3e30a4526b46394baed1e1e5a
Autor:
Juan Morote, Miriam Campistol, Marina Triquell, Anna Celma, Lucas Regis, Inés de Torres, Maria E. Semidey, Richard Mast, Anna Santamaria, Jacques Planas, Enrique Trilla
Publikováno v:
European Urology Open Science, Vol 37, Iss , Pp 38-44 (2022)
Background: Prostate Imaging-Reporting and Data System (PI-RADS) category 3 is a challenging scenario for detection of clinically significant prostate cancer (csPCa) and some tools can improve the selection of appropriate candidates for prostate biop
Externí odkaz:
https://doaj.org/article/cd89f67328fe45c8ab108a9618157aaf
Autor:
Cristina Suarez, David Marmolejo, Augusto Valdivia, Rafael Morales-Barrera, Macarena Gonzalez, Joaquin Mateo, Maria Eugenia Semidey, David Lorente, Enrique Trilla, Joan Carles
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Collecting duct renal cell carcinoma (cdRCC), which until recently was thought to arise from the collecting ducts of Bellini in the renal medulla, is a rare and aggressive type of non-clear renal cell carcinoma (ncRCC), accounting for 1% of all renal
Externí odkaz:
https://doaj.org/article/76d867817a8c43dba11b886e3239f14f
Autor:
Jazmine Arévalo, David Lorente, Enrique Trilla, María Teresa Salcedo, Juan Morote, Anna Meseguer
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Clear cell renal cell carcinoma (ccRCC) is the most frequent and aggressive subtype of renal carcinoma. So far, the basis of its oncogenesis remains unclear resulting in a deficiency of usable and reliable biomarkers for its clinical managem
Externí odkaz:
https://doaj.org/article/80cfc50f69ef4fbaa7ed0f5fd8c11aea
Autor:
Lidia Moserle, Roser Pons, Mar Martínez‐Lozano, Gabriela A Jiménez‐Valerio, August Vidal, Cristina Suárez, Enrique Trilla, José Jiménez, Inés de Torres, Joan Carles, Jordi Senserrich, Susana Aguilar, Luis Palomero, Alberto Amadori, Oriol Casanovas
Publikováno v:
EMBO Molecular Medicine, Vol 12, Iss 12, Pp 1-17 (2020)
Abstract An open debate in antiangiogenic therapies is about their consequence on tumor invasiveness and metastasis, which is undoubtedly relevant for patients currently treated with antiangiogenics, such as renal cell carcinoma patients. To address,
Externí odkaz:
https://doaj.org/article/37c72f66a1ce49acaeef8a135ab7206f
Publikováno v:
European Urology Open Science, Vol 42, Iss , Pp 40-41 (2022)
Externí odkaz:
https://doaj.org/article/1b00363944254aa29012db3519cefb09